• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4-[ω-[4-芳基哌嗪-1-基]烷氧基]苯基)咪唑并[1,2-a]吡啶衍生物:作为受体可视化潜在探针的荧光高亲和力多巴胺D3受体配体。

4-[omega-[4-arylpiperazin-1-yl]alkoxy]phenyl)imidazo[1,2-a]pyridine derivatives: fluorescent high-affinity dopamine D3 receptor ligands as potential probes for receptor visualization.

作者信息

Leopoldo Marcello, Lacivita Enza, Passafiume Elena, Contino Marialessandra, Colabufo Nicola A, Berardi Francesco, Perrone Roberto

机构信息

Dipartimento Farmaco-Chimico, Università degli Studi di Bari, Via Orabona, 4, 70125 Bari, Italy.

出版信息

J Med Chem. 2007 Oct 4;50(20):5043-7. doi: 10.1021/jm070721+. Epub 2007 Sep 12.

DOI:10.1021/jm070721+
PMID:17850060
Abstract

Sixteen long-chain arylpiperazines bearing the fluorescent moiety 2-phenylimidazo[1,2-a]pyridine were synthesized as fluorescent dopamine D3 receptors ligands (385 nM < Ki < 0.72 nM). The most potent D3 compounds 15a and 19a (Ki = 1.6 and 0.72 nM, respectively) showed good Stokes shift and high quantum yield in ethanol (Phi = 0.74 and 0.66, respectively). In the first attempt, 15a was unable to visualize D3 receptors expressed in CHO cells by epifluorescence microscopy.

摘要

合成了16种带有荧光部分2-苯基咪唑并[1,2-a]吡啶的长链芳基哌嗪作为荧光多巴胺D3受体配体(385 nM < Ki < 0.72 nM)。最有效的D3化合物15a和19a(Ki分别为1.6和0.72 nM)在乙醇中表现出良好的斯托克斯位移和高量子产率(分别为Phi = 0.74和0.66)。在首次尝试中,15a无法通过落射荧光显微镜观察到CHO细胞中表达的D3受体。

相似文献

1
4-[omega-[4-arylpiperazin-1-yl]alkoxy]phenyl)imidazo[1,2-a]pyridine derivatives: fluorescent high-affinity dopamine D3 receptor ligands as potential probes for receptor visualization.4-[ω-[4-芳基哌嗪-1-基]烷氧基]苯基)咪唑并[1,2-a]吡啶衍生物:作为受体可视化潜在探针的荧光高亲和力多巴胺D3受体配体。
J Med Chem. 2007 Oct 4;50(20):5043-7. doi: 10.1021/jm070721+. Epub 2007 Sep 12.
2
Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.新型N-{4-[4-(2,3-二氯苯基)哌嗪-1-基]丁基}芳基羧酰胺的杂环反式烯烃类似物作为对多巴胺D3受体具有高亲和力的选择性探针。
J Med Chem. 2005 Feb 10;48(3):839-48. doi: 10.1021/jm049465g.
3
Synthesis and characterization of environment-sensitive fluorescent ligands for human 5-HT1A receptors with 1-arylpiperazine structure.具有1-芳基哌嗪结构的人5-HT1A受体环境敏感型荧光配体的合成与表征
J Med Chem. 2009 Dec 10;52(23):7892-6. doi: 10.1021/jm900706d.
4
First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamide structure.关于具有N-[4-(4-芳基哌嗪-1-基)丁基]芳基甲酰胺结构的多巴胺D3受体剂的首次构效关系研究。
J Med Chem. 2005 Dec 15;48(25):7919-22. doi: 10.1021/jm050729o.
5
2-[(4-phenylpiperazin-1-yl)methyl]imidazo(di)azines as selective D4-ligands. Induction of penile erection by 2-[4-(2-methoxyphenyl)piperazin-1-ylmethyl]imidazo[1,2-a]pyridine (PIP3EA), a potent and selective D4 partial agonist.2-[(4-苯基哌嗪-1-基)甲基]咪唑并[1,2-a]哒嗪类作为选择性D4配体。强效选择性D4部分激动剂2-[4-(2-甲氧基苯基)哌嗪-1-基甲基]咪唑并[1,2-a]吡啶(PIP3EA)诱导阴茎勃起。
J Med Chem. 2006 Jun 29;49(13):3938-47. doi: 10.1021/jm060166w.
6
Design and synthesis of 2-phenylimidazo[1,2-a]pyridines as a novel class of melatonin receptor ligands.设计和合成 2-苯基咪唑并[1,2-a]吡啶类作为新型褪黑素受体配体。
Eur J Med Chem. 2011 Sep;46(9):4252-7. doi: 10.1016/j.ejmech.2011.06.030. Epub 2011 Jul 1.
7
Phenylpiperazinylmethylheterocycle derivatives: synthesis and dopamine receptor binding profiles.苯基哌嗪基甲基杂环衍生物:合成与多巴胺受体结合特性
Arch Pharm (Weinheim). 2004 Jul;337(7):383-90. doi: 10.1002/ardp.200300838.
8
Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligands.新型1,2,3,4-四氢异喹啉衍生物及密切相关化合物作为强效和选择性多巴胺D3受体配体的开发。
Chembiochem. 2004 Apr 2;5(4):508-18. doi: 10.1002/cbic.200300784.
9
Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype.[(2,3-二氯苯基)哌嗪-1-基]烷基芴基羧酰胺作为多巴胺D3受体亚型选择性新型配体的设计与合成
J Med Chem. 2001 Sep 13;44(19):3175-86. doi: 10.1021/jm010146o.
10
Synthesis and binding studies of epibatidine analogues as ligands for the nicotinic acetylcholine receptors.作为烟碱型乙酰胆碱受体配体的埃博霉素类似物的合成与结合研究。
Eur J Med Chem. 2006 May;41(5):640-50. doi: 10.1016/j.ejmech.2006.01.015. Epub 2006 Mar 20.

引用本文的文献

1
Synthesis, biological evaluation, and molecular docking of novel hydroxyzine derivatives as potential AR antagonists.新型羟嗪衍生物作为潜在雄激素受体拮抗剂的合成、生物学评价及分子对接
Front Chem. 2022 Nov 3;10:1053675. doi: 10.3389/fchem.2022.1053675. eCollection 2022.
2
Synthesis, bioactivity, and molecular docking of novel arylpiperazine derivatives as potential AR antagonists.新型芳基哌嗪衍生物作为潜在雄激素受体拮抗剂的合成、生物活性及分子对接
Front Chem. 2022 Aug 15;10:947065. doi: 10.3389/fchem.2022.947065. eCollection 2022.
3
Differently fluorescence-labelled dibenzodiazepinone-type muscarinic acetylcholine receptor ligands with high MR affinity.
具有高MR亲和力的不同荧光标记的二苯并二氮杂䓬酮型毒蕈碱型乙酰胆碱受体配体。
RSC Med Chem. 2020 Jun 8;11(7):823-832. doi: 10.1039/d0md00137f. eCollection 2020 Jul 1.
4
Synthesis and cytotoxic activity evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines.新型芳基哌嗪衍生物对人前列腺癌细胞系的合成及细胞毒性活性评估
Molecules. 2014 Aug 12;19(8):12048-64. doi: 10.3390/molecules190812048.
5
Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors.用于理解配体与G蛋白偶联受体相互作用的荧光方法。
Biochim Biophys Acta. 2014 Jan;1838(1 Pt A):15-33. doi: 10.1016/j.bbamem.2013.09.005. Epub 2013 Sep 18.
6
Synthesis and characterization of selective dopamine D₂ receptor ligands using aripiprazole as the lead compound.使用阿立哌唑作为先导化合物,合成并表征选择性多巴胺 D₂ 受体配体。
Bioorg Med Chem. 2011 Jun 1;19(11):3502-11. doi: 10.1016/j.bmc.2011.04.021. Epub 2011 Apr 16.